Why do breast cancer patients need dental clearance and dental work finished before starting chemotherapy?

Chemotherapy temporarily lowers white blood cells (neutropenia). If you have cavities, impacted wisdom teeth, or gum infection, oral bacteria can enter the bloodstream and cause severe infection. If bisphosphonates or denosumab are later needed, tooth extraction after starting those drugs raises the risk of medication-related osteonecrosis of the jaw (MRONJ/ONJ). Dental clearance should therefore be completed beforehand.

Why is heart testing (ECG / echocardiogram) important before starting breast cancer chemotherapy?

Anthracyclines (such as doxorubicin, epirubicin) and some targeted agents such as trastuzumab can affect heart muscle. ECG and/or echocardiogram establish a baseline so the team can judge safety before starting therapy and monitor during treatment.

What does pathology ER+, PR−, HER2 (1+ or 2+), Ki67 20% mean, and how is treatment planned?

High ER+ means good responsiveness to endocrine (anti-hormone) therapy. PR− means no progesterone receptor expression. HER2 1+ is usually considered HER2-negative/HER2-low; 2+ needs FISH/ISH confirmation, and if positive, trastuzumab may be considered. Ki67 ~20% is an intermediate proliferation rate. After lumpectomy, radiation is usually required; the team often considers chemotherapy based on risk factors, then endocrine therapy.

After lumpectomy (breast-conserving surgery), is radiation always required?

In nearly all breast-conserving cases, breast radiation is a core part of standard care to reduce local recurrence in the same breast. Rare exceptions are decided only by a multidisciplinary team based on age, stage, and comorbidities.

What should happen next if HER2 is 2+?

IHC 2+ is an equivocal result. Per ASCO/CAP guidelines, confirmatory FISH or ISH is required. If confirmed positive, anti-HER2 targeted therapy is planned.

What is the usual treatment sequence after lumpectomy?

Often chemotherapy when indicated → radiation → endocrine therapy for 5–10 years. If HER2 is positive, targeted therapy is added per plan. The real sequence depends on staging, pathology, and surgery details.

Category: Oncology & Breast Cancer Care

After breast-conserving surgery, how should you prepare? Dental clearance, heart checks, and decoding ER/PR/HER2/Ki67

By
Asst. Prof. Dr. Norawit Raatpiboon
(ผศ.ดร.นรวิชญ์ ราษฎร์พิบูลย์) · Last updated: August 2026 · Lumpectomy · Pre-chemo prep · Pathology

Toothache, cheek swelling, pus, or fever — complete oral clearance before starting chemo or bone-modifying agents
Shortness of breath, leg swelling, palpitations, or chest pain before/during cardiotoxic drugs
Starting tooth extraction or wisdom-tooth surgery yourself after bisphosphonate/denosumab without telling the oncology team
HER2 2+ result without planned confirmatory FISH/ISH
After breast-conserving surgery with no radiation plan yet — confirm with the multidisciplinary team

Direct answer (BLUF):
Pre-chemotherapy preparation for breast cancer requires
dental clearance to prevent severe infection during neutropenia and to lower
MRONJ/ONJ
risk if bone-modifying agents are used, plus
ECG/Echo to reduce cardiotoxicity risk from
anthracyclines.
Pathology showing ER+ PR− HER2 (1+/2+) Ki67 ~20%
points to hormone-responsive disease with intermediate proliferation.
After lumpectomy, radiation is usually required,
with chemotherapy and endocrine therapy considered by risk.

1. Why finish dental work before chemo? Dental clearance and neutropenia explained

Dental clearance is not just a cosmetic cleaning. It reduces oral infection sources before the body enters a high-risk window after chemotherapy.

Preventing infection during neutropenia

Chemotherapy suppresses the bone marrow and temporarily lowers white blood cells.
If cavities, impacted wisdom teeth, gingivitis, or periapical abscesses are present,
oral bacteria can enter the bloodstream and cause
neutropenic infection, which can be life-threatening.

Preventing osteonecrosis of the jaw (ONJ / MRONJ)

In breast cancer, the team may consider
bisphosphonates or denosumab
to protect bone or reduce skeletal involvement.
Extraction or jaw surgery while on these agents raises the risk of
medication-related osteonecrosis of the jaw (MRONJ).
Complete dental procedures before starting those drugs.

2. ECG/Echo: protecting the heart muscle before anthracyclines

Many standard breast cancer regimens include
anthracyclines such as doxorubicin or epirubicin (“red chemo”),
and some plans include trastuzumab when HER2 is positive —
both groups can affect cardiac contractility (cardiotoxicity).

ECG: baseline rhythm and conduction assessment
Echocardiogram: baseline LVEF and cardiac function
Used for comparison during treatment; if function declines, the team adjusts the plan

Pre-treatment heart testing is a safety net — not always a sign that the heart is already diseased.

Preparing for chemo and also having chest tightness or heartburn?

Review symptom severity and get personalized guidance from our Advisory team

Open the free GERD Severity Score

3. Decoding the pathology report: What do ER 80%, PR−, HER2 (1+/2+), Ki67 20% tell us?

Immunohistochemistry (IHC) maps the tumor’s biology, following
ASCO/CAP HER2 testing
and
NCI breast cancer treatment
guidance.

Table: Interpreting pathology markers
Pathology marker	Example result	Clinical meaning	Related treatment direction
ER (Estrogen Receptor)	80% positive	Cancer cells strongly use estrogen to grow	Endocrine therapy (e.g. tamoxifen or an aromatase inhibitor such as letrozole), often 5–10 years
PR (Progesterone Receptor)	Negative (−)	No progesterone receptor expression	ER+ plans still apply, but the team may view risk as higher than ER+/PR+
HER2 IHC	1+ or 2+	1+ ≈ HER2-negative/HER2-low · 2+ = equivocal, needs confirmation	2+ → FISH/ISH · if positive, consider anti-HER2 (e.g. trastuzumab)
Ki67	~20%	Intermediate proliferation rate	Combined with other factors when deciding on chemotherapy

Note: Interpretation must include staging, surgical margins, lymph nodes, and comorbidities —
pathology numbers alone are not a complete treatment plan.

4. Treatment after breast-conserving surgery: chemo, radiation, and endocrine therapy

After lumpectomy (breast-conserving surgery),
most standard pathways include
radiation therapy to the breast
to reduce local recurrence in the same breast.

Common sequence

Chemotherapy when indicated (e.g. stage, tumor size, nodes, high Ki67, or other risk factors)
Radiation after chemo (or in the order the team sets)
Endocrine therapy for 5–10 years when ER+
Anti-HER2 targeted therapy if FISH/ISH confirms positivity

Table: Pre-chemotherapy medical clearance checklist
Test / procedure	Medical rationale	Risk if skipped before therapy
Dental clearance	Reduce oral infection sources · prepare before bisphosphonate/denosumab	Neutropenic sepsis · MRONJ after extraction on bone agents
ECG ± Echocardiogram	Baseline before anthracycline / trastuzumab	Delayed detection of cardiotoxicity · late regimen adjustment
Confirm HER2 (FISH/ISH if 2+)	Identify who needs targeted therapy	Miss anti-HER2 benefit or give unnecessary therapy
Plan radiation after lumpectomy	Standard to reduce local recurrence	Higher same-breast recurrence if omitted without a clear exception

Comparing plan components after breast conservation

Approach	Examples	Strengths	Limitations
Chemotherapy	Anthracycline / taxane regimens per plan	Lowers recurrence risk in higher-risk cases	Side effects · needs dental and cardiac clearance first
Radiation	Whole-breast or partial per radiation oncology	Needed in nearly all post-lumpectomy cases	Scheduling after wound healing / after chemo
Endocrine therapy	Tamoxifen or aromatase inhibitor	Core pillar when ER+	Long duration · agent-specific side effects
HER2-targeted therapy	Trastuzumab ± other agents when FISH+	Reduces recurrence in HER2+	Requires confirmed HER2 status · cardiac monitoring
Bone-modifying agents	Bisphosphonate / denosumab when indicated	Bone protection	Dental clearance first to reduce MRONJ

Frequently asked questions (FAQ)

Why is dental clearance needed before chemotherapy?

To lower severe infection risk during neutropenia and to reduce MRONJ risk if bone-modifying agents are used later.

Why is heart testing important before chemo?

It provides a baseline before anthracycline and/or trastuzumab so cardiotoxicity can be monitored and prevented.

What does ER+ PR− HER2 1+/2+ Ki67 20% mean?

Strong endocrine responsiveness (ER+) · PR− · HER2 1+ usually negative/low while 2+ needs FISH/ISH ·
intermediate Ki67 — teams often consider chemo + radiation + endocrine therapy after lumpectomy.

Is radiation required after every breast-conserving case?

In nearly all cases, yes — to reduce local recurrence. Exceptions are case-specific decisions by a multidisciplinary team only.

What next if HER2 is 2+?

Confirm with FISH or ISH. If positive, plan anti-HER2 targeted therapy.

What is the usual sequence after lumpectomy?

Chemo (if indicated) → radiation → endocrine therapy for 5–10 years (± targeted therapy if HER2+)

Scientific mechanism: pathology markers, body clearance, and complication prevention

Written by
Asst. Prof. Dr. Norawit Raatpiboon

ER/PR are nuclear receptors that drive growth of hormone-positive cancer cells.
HER2 is a cell-surface receptor that activates growth pathways — IHC 2+ must be confirmed at the gene level (FISH/ISH).
Ki67 reflects the share of cells in the proliferative cycle.

Anthracyclines cause cardiotoxicity via oxidative stress and cardiomyocyte injury.
During neutropenia, oral infection clearance drops sharply —
hence dental clearance and baseline cardiac assessment before starting systemic therapy.

Academic citations (E-E-A-T)

Author:
Asst. Prof. Dr. Norawit Raatpiboon
(ผศ.ดร.นรวิชญ์ ราษฎร์พิบูลย์)

Medical disclaimer:
This article is for general education only and is not individualized medical advice.
Pathology interpretation and treatment sequencing must be decided with a multidisciplinary team.
For urgent oral or cardiac symptoms, contact a physician immediately.